Last viewed:
PRGO
Prices are updated after-hours
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
(0.0% 1d)
(-4.0% 1m)
(-16.3% 1y)
(0.0% 2d)
(0.0% 3d)
(-0.3% 7d)
(-100.0%
volume)
Earnings Calendar:
Market Cap: $ 4,173,890,921
http://www.perrigo.com
Sec
Filling
|
Patents
| 11200 employees
(IE) Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The firm operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the U.S., Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with consumer-focused businesses in the U.K. and Australia. The Prescription Pharmaceuticals commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
israel
brands
diagnostics
Drugs
ESTRADIOL VALERATE
(ESTRADIOL VALERATE )
add to watch list
Paper trade
email alert is off
Press-releases
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19
(Crawled : 15:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
| 0.0%
| O: -0.13%
H: 0.0%
C: 0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
| 0.0%
| O: 0.79%
H: 0.0%
C: 0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
| 0.0%
| O: -0.75%
H: 0.0%
C: 0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| 0.0%
| O: 0.82%
H: 0.0%
C: 0.0%
first
treatment
for
AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12
(Crawled : 14:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
| -3.96%
| O: -0.13%
H: 0.0%
C: -2.94%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
| -3.82%
| O: -1.65%
H: 0.0%
C: 0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
| -4.53%
| O: -1.06%
H: 0.21%
C: -1.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -4.0%
| O: -3.02%
H: 0.0%
C: 0.0%
drug
label
astrazeneca
expansion
for
kids
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
| 0.01%
| O: 2.24%
H: 0.0%
C: -0.8%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
| -4.33%
| O: 0.96%
H: 1.17%
C: 0.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
| -4.97%
| O: -0.48%
H: 0.0%
C: 0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
| -4.32%
| O: 0.09%
H: 0.16%
C: -0.7%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -3.02%
| O: 0.84%
H: 0.0%
C: 0.0%
for
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
| -3.54%
| O: -1.77%
H: 0.0%
C: -1.81%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
| -4.48%
| O: -0.22%
H: 0.8%
C: 0.06%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
| -6.72%
| O: -1.84%
H: 0.0%
C: 0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
| -3.37%
| O: -0.37%
H: 1.42%
C: 1.37%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -6.35%
| O: -3.44%
H: 0.0%
C: 0.0%
fda
for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03
(Crawled : 13:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
| -4.09%
| O: -0.29%
H: 1.34%
C: -0.64%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
| -8.1%
| O: 0.02%
H: 0.0%
C: 0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
| -5.02%
| O: 0.11%
H: 0.37%
C: -0.77%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -4.59%
| O: 0.69%
H: 0.0%
C: 0.0%
fda
drug
schizophrenia
AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02
(Crawled : 13:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
| -6.45%
| O: -1.09%
H: 0.13%
C: -1.39%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
| -8.13%
| O: -0.77%
H: 0.8%
C: 0.74%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
| -5.08%
| O: -0.18%
H: 0.47%
C: 0.12%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -6.67%
| O: -1.14%
H: 0.02%
C: -1.06%
approval
astrazeneca
Global Immune Health Supplements Outlook Report 2023-2029: Vendors Focus on Advancements and Quality, Creating Competition by Offering Innovative Solutions
Published: 2024-03-29
(Crawled : 11:00)
- prnewswire.com
BRBR
|
$53.98
-0.46%
0.0%
990K
|
Health Technology
| Email alert
Add to watchlist
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
| Email alert
Add to watchlist
MEDE
|
News
|
$0.51
0%
500
|
n/a
| Email alert
Add to watchlist
report
health
offering
global
solutions
FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29
(Crawled : 19:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
| Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
| Email alert
Add to watchlist
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
| Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
| Email alert
Add to watchlist
fda
hepatitis
kidney
anemia
FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
| -7.26%
| O: -0.26%
H: 0.0%
C: 0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
| -2.47%
| O: 0.84%
H: 1.48%
C: 1.29%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
| -6.86%
| O: 0.3%
H: 0.0%
C: 0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
| -3.65%
| O: 1.48%
H: 0.0%
C: 0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -7.5%
| O: 1.06%
H: 0.0%
C: 0.0%
fda
rare
IONETIX announces appointment of Douglas Boothe to Board of Directors
Published: 2024-03-26
(Crawled : 11:00)
- prnewswire.com
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
| -3.13%
| O: 0.48%
H: 0.0%
C: -1.16%
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001585364-24-000063
4
2024-04-09
2024-04-05
Buy
A
13376
13376
0001585364-24-000062
4
2024-04-09
2024-04-05
Buy
A
17197
17197
0001585364-24-000061
4
2024-04-09
2024-04-05
Buy
A
6210
6210
0001585364-24-000060
4
2024-04-09
2024-04-05
Buy
A
53503
53503
0001585364-24-000059
4
2024-04-09
2024-04-05
Buy
A
17197
17197